Guanosine 5'-monophosphate disodium salt

CAS: 5550-12-9

Ref. 3D-NG02982

Produktinformation

• Name: Guanosine 5'-monophosphate disodium salt
• Synonyme: 5'-Guanylic acid disodium, 2-amino-9-(5-O-phosphonopentofuranosyl)-3,9-dihydro-6H-purin-6-one, 5'-Guanylic acid hydrate, 5'-Guanylic acid, disodium salt, 5'-O-phosphonatoguanosine, 5′-GMP disodium salt, 5′-Guanylic acid, sodium salt (1:2), Disodium 5′-GMP, Disodium GMP, Disodium guanosine 5′-monophosphate, Disodium guanosine 5′-phosphate, Disodium guanosine monophosphate, Disodium guanylate, E 627, GMP disodium salt, GMP sodium salt, Guanosine 5[-monophosphate, disodium salt hydrate, Guanosine 5′-phosphate disodium salt, Guanosine-5'-monophosphate, disodium salt, Guanylic acid sodium salt, NSC 20265, Sodium 5′-guanylate, Sodium GMP, Sodium guanosine 5′-monophosphate, Sodium guanylate, disodium 2-amino-9-(5-O-phosphonatopentofuranosyl)-3,9-dihydro-6H-purin-6-one, disodium 5'-O-phosphonatoguanosine

Beschreibung

Guanosine 5'-monophosphate disodium salt (GMPDS) is an antiviral agent that inhibits the synthesis of viral nucleic acids by competitive inhibition of the enzyme ribonucleotide reductase. GMPDS has been shown to inhibit the replication of a number of RNA viruses, including influenza A and B, herpes simplex virus type 1, and human immunodeficiency virus type 1. This drug also has been shown to decrease cyclic adenosine monophosphate (cAMP) levels in cells by inhibiting phosphodiesterase activity. GMPDS is used for treatment of infectious diseases such as influenza A, herpes, and HIV-1.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 407.18 g/mol
• Formel: C₁₀H₁₂N₅Na₂O₈P
• Reinheit: Min. 98 Area-%
• Farbe/Form: White Off-White Powder